Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
European Journal of Nuclear Medicine
|
January 1, 1992
Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease
T Kuwert, H Hefter, D Scholz, et al.
Der Nervenarzt
|
March 27, 2009
[Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions]
I W Husstedt, D Reichelt, E Neuen-Jakob, et al.
Journal of Neurology
|
October 27, 2004
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies
K Hahn, G Arendt, J S Braun, et al.
Journal of Neurology
|
February 26, 2009
Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV
Mark Obermann, M Küper, O Kastrup, et al.
European Journal of Medical Research
|
April 22, 2009
HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV
H Kremer, U Sonnenberg-Schwan, G Arendt, et al.
Infection
|
January 12, 2011
Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS
A Plettenberg, N H Brockmeyer, B Haastert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 3, 2016
The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection
Anne Horn, C Scheller, S du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2010
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C Scheller, G Arendt, T Nolting, et al.
Current Medical Research and Opinion
|
March 1, 2013
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain
R-D Treede, T Wagner, K-U Kern, et al.
Neurology
|
October 5, 2007
Updated research nosology for HIV-associated neurocognitive disorders
A Antinori, G Arendt, J T Becker, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
European Journal of Nuclear Medicine
|
January 1, 1992
Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease
T Kuwert, H Hefter, D Scholz, et al.
Der Nervenarzt
|
March 27, 2009
[Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions]
I W Husstedt, D Reichelt, E Neuen-Jakob, et al.
Journal of Neurology
|
October 27, 2004
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies
K Hahn, G Arendt, J S Braun, et al.
Journal of Neurology
|
February 26, 2009
Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV
Mark Obermann, M Küper, O Kastrup, et al.
European Journal of Medical Research
|
April 22, 2009
HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV
H Kremer, U Sonnenberg-Schwan, G Arendt, et al.
Infection
|
January 12, 2011
Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS
A Plettenberg, N H Brockmeyer, B Haastert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 3, 2016
The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection
Anne Horn, C Scheller, S du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2010
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C Scheller, G Arendt, T Nolting, et al.
Current Medical Research and Opinion
|
March 1, 2013
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain
R-D Treede, T Wagner, K-U Kern, et al.
Neurology
|
October 5, 2007
Updated research nosology for HIV-associated neurocognitive disorders
A Antinori, G Arendt, J T Becker, et al.
Page
of 8